Cargando…
Clinical Trials of Antiangiogenesis Therapy on Gastric Cancer
Both malignant tumor growth and metastasis are dependent upon angiogenesis, a process of new blood vessel formation. Inhibition of this process by specific inhibitors might be able to control tumor growth and metastasis. Therefore, antiangiogenesis thereapy is considered a promising strategy and bei...
Autores principales: | Wu, Li Cun, Zhang, Wei Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154210/ https://www.ncbi.nlm.nih.gov/pubmed/27994701 http://dx.doi.org/10.4021/gr2008.11.1250 |
Ejemplares similares
-
Surrogate markers in antiangiogenesis clinical trials
por: Davis, D W, et al.
Publicado: (2003) -
Antiangiogenesis Therapy for Breast Cancer: An Update and Perspectives from Clinical Trials
por: Fakhrejahani, Elham, et al.
Publicado: (2014) -
Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer
por: Li, Song, et al.
Publicado: (2023) -
Antiangiogenesis therapy: an update after the first decade
por: De Falco, Sandro
Publicado: (2014) -
Microbiome Crosstalk in Immunotherapy and Antiangiogenesis Therapy
por: Wan, Xueting, et al.
Publicado: (2021)